The Trade Desk Reports Second Quarter Financial Results
Aug 10, 2017 20:01 pm UTC| Business
LOS ANGELES, Aug. 10, 2017 -- The Trade Desk, Inc. (NASDAQ:TTD), a provider of a global technology platform for buyers of advertising, today announced financial results for its second quarter ended June 30, 2017. ...
SWK Holdings Corporation Announces 2017 Second Quarter Financial Results
Aug 10, 2017 20:01 pm UTC| Business
Total revenues of approximately $6.1 million for the second quarter of 2017 compared to $8.6 million for the second quarter of 2016. Net income attributable to SWK Shareholders of $3.4 million, or $0.26 per share, and...
Navigators Promotes Pat Milner to President of NavTech
Aug 10, 2017 20:01 pm UTC| Business
STAMFORD, Conn., Aug. 10, 2017 -- The Navigators Group, Inc. (NASDAQ:NAVG) today announced the promotion of Patrick J. Milner to President of NavTech, the company’s global business unit underwriting upstream and...
Ideal Power Reports Second Quarter 2017 Financial Results
Aug 10, 2017 20:01 pm UTC| Business
AUSTIN, Texas, Aug. 10, 2017 -- Ideal Power Inc. (NASDAQ:IPWR), an innovative power conversion technology company, reported results for the three and six months ended June 30, 2017. Key Second Quarter 2017 and...
CareDx Reports Second Quarter 2017 Financial Results
Aug 10, 2017 20:01 pm UTC| Business
BRISBANE, Calif., Aug. 10, 2017 -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions...
21Vianet Group, Inc. Announces the Pricing of USD200 Million Notes
Aug 10, 2017 20:01 pm UTC| Business
BEIJING, Aug. 10, 2017 -- 21Vianet Group, Inc. (Nasdaq:VNET) ("21Vianet" or the "Company"), a leading carrier-neutral Internet data center services provider in China, today announced that the Company has priced the...
CymaBay Reports Second Quarter 2017 Financial Results and Provides Corporate Update
Aug 10, 2017 20:01 pm UTC| Business
NEWARK, Calif., Aug. 10, 2017 -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today...